This case highlights the importance of early recognition of SGLT2 inhibitor-associated EuDKA, particularly when complicated by lactic acidosis, and emphasizes the potential role of hemodialysis in managing refractory metabolic acidosis to prevent further clinical deterioration, even with modest hyperglycemia. The gene discussed is SLC5A2; the disease is metabolic acidosis.